Stockscreener 앱 받기
15.39
1.35%
-0.21
시간 외 거래:
15.69
0.30
+1.95%
전일 마감가:
$15.60
열려 있는:
$15.52
하루 거래량:
17.26M
Relative Volume:
5.02
시가총액:
$3.97B
수익:
$6.41B
순이익/손실:
$1.30B
주가수익비율:
3.0536
EPS:
5.04
순현금흐름:
$646.00M
1주 성능:
+0.52%
1개월 성능:
-0.65%
6개월 성능:
-21.04%
1년 성능:
-15.90%
1일 변동 폭
$15.25
$15.68
1주일 범위
$15.25
$15.88
52주 변동 폭
$13.87
$23.10
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
OGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
15.39 | 3.97B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
837.57 | 752.28B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
210.01 | 370.74B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
163.63 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
76.86 | 341.19B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
93.11 | 235.20B | 64.17B | 17.12B | 18.10B | 6.73 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-09-21 | 개시 | Barclays | Overweight |
| 2023-03-16 | 개시 | Raymond James | Outperform |
| 2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 개시 | Piper Sandler | Neutral |
| 2021-09-01 | 개시 | BofA Securities | Buy |
| 2021-07-22 | 개시 | Citigroup | Buy |
| 2021-06-15 | 개시 | JP Morgan | Neutral |
| 2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
(OGN) Technical Data - Stock Traders Daily
Organon (OGN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon (OGN) Advances While Market Declines: Some Information for Investors - MSN
Why Organon Is A Top Pick For Income Investors (NYSE:OGN) - Seeking Alpha
Is Organon & Co. (OGN) the Deep Value Stock to Buy Now? - Insider Monkey
Organon & Co. (NYSE:OGN) Receives $20.80 Consensus Target Price from Analysts - Defense World
Organon & Co. (NYSE:OGN) Shares Sold by US Bancorp DE - Defense World
Organon & Co (OGN) Trading Down 2.88% on Mar 12 - GuruFocus.com
Organon’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia
Organon’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
Trend Tracker for (OGN) - Stock Traders Daily
Proficio Capital Partners LLC Acquires New Holdings in Organon & Co. (NYSE:OGN) - Defense World
Healthcare Veteran Appointed CEO of May Health's Groundbreaking PCOS Technology - StockTitan
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older - BioSpace
MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO - Quantisnow
Organon announes results from analysis of Phase 3 ADORING 3 study - TipRanks
Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results - StockTitan
Organon and Partners Advance Women’s Health Innovation to Drive Economic and Social Growth in Southeast Asia - The Hastings Tribune
Organon and partners drive innovation to strengthen healthcare access - Bangkok Post
Organon & Co. (NYSE:OGN) Shares Sold by Private Advisor Group LLC - Defense World
Truist Financial Corp Increases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
(OGN) Long Term Investment Analysis - Stock Traders Daily
Principal Financial Group Inc. Raises Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Common Retirement Fund Buys 43,928 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Up 5.7%Here's What Happened - MarketBeat
A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Is Organon & Co. (OGN) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey
Rhumbline Advisers Sells 14,051 Shares of Organon & Co. (NYSE:OGN) - Defense World
Principal Financial Group Inc. Buys 32,485 Shares of Organon & Co. (NYSE:OGN) - Defense World
The Hidden Gems of the Pharma World: Stocks Analysts Can’t Ignore - jomfruland.net
Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
10 Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
Allspring Global Investments Holdings LLC Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
1.54%
자본화:
|
볼륨(24시간):